Differential Target Multiplexed Spinal Cord Stimulation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMoens Maarten
About this trial
Evaluation of the effectiveness of differential target multiplexed spinal cord stimulation for treatment of chronic back and leg pain. Additionally, a subgroup analysis will be performed to evaluate potential differences between paddle/surgical leads versus percutaneous leads.
Eligibility criteria
Qualifiers
Patients with severe chronic pain (> 5 on numeric rating scale, NRS) for at least 6 months due to FBSS (PSPS T2) and suitable for treatment with DTM SCS according to the treating physician
Age > 18 years
Patient has been informed of the study procedures and has given written informed consent
Patient willing to comply with study protocol including attending the study visits
Disqualifiers
Expected inability of the patient to receive or properly operate the spinal cord stimulation system
History of coagulation disorder, lupus erythematosus, diabetic neuropathy, rheumatoid arthritis, or morbus Bechterew
Active malignancy
Addiction to drugs, alcohol (>5 units per day) and/or medication
Trial design
Treatments tested in this trial
- Spinal Cord Stimulation
Treatment groups
250 Participants
are divided into 1 treatment groupSponsors and collaborators
Moens Maarten
Lead sponsor
Universitair Ziekenhuis Brussel
Sponsor institution
Source ClinicalTrials.gov